Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: Results from the prospective, multicentre, non-randomised BIPAX clinical trial

EuroIntervention

Volumn 7, Issue 11, 2012, Pages 1301-1309

  Costa, Ricardo A ^a,b   Abizaid, Alexandre ^a,b   Abizaid, Andrea S ^a,b   Del Blanco, Bruno Garcia ^c   Berland, Jacques ^d   Petrov, Ivo ^e   Brenot, Philippe ^f   Van Guens, Robert Jan ^g   Royer, Thierry ^h   Rubino, Paolo ⁱ   Lesiak, Maciej ^j   Fajadet, Jean ^k  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b Cardiovascular Research Center   (Brazil)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Clinique Saint Hilaire   (France)

^e Tokuda Hospital   (Bulgaria)

^f Centre Cardiologique d'Evecquemont   (France)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^h CENTRE CARDIOLOGIQUE DU NORD   (France)

ⁱ Casa di Cura Montevergine ^*  (Italy)

^j POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^k CLINIQUE PASTEUR   (France)

more..

Author keywords

Bifurcation; Dedicated bifurcation stents; Drug coated stents; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BIFURCATION LESION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; SURGICAL TECHNIQUE; THROMBOSIS; THROMBOSIS PREVENTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHROMIUM ALLOYS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; TUBULIN MODULATORS;

EID: 84859016140     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I11A205     Document Type: Article

References (24)

1. Latib A, Colombo A. Bifurcation disease: What dowe know, what should we do? JACC Cardiovasc Interv. 2008;1:218-226. (Pubitemid 351804179)
2. Costa RA, Moussa ID. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents. Minerva cardioangiologica. 2006;54:577-589. (Pubitemid 44702088)
3. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L. Randomized study onsimple versus complex stenting of coronary artery bifurcation lesions: The NORDIC bifurcation study. Circulation. 2006;114:1955-1961. (Pubitemid 44665390)
4. Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Kuebler P, Buttner HJ, Neumann FJ. Randomized trial onroutine vs. Provisional t-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J. 2008;29:2859-2867.
5. Hildick-Smith D, de Belder AJ, Cooter N, Curzen NP, Clayton TC, Oldroyd KG, Bennett L, Holmberg S, Cotton JM, Glennon PE, Thomas MR, Maccarthy PA, Baumbach A, Mulvihill NT, Henderson RA, Redwood SR, Starkey IR, Stables RH. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: The British Bifurcation Coronary study: Old, new, and evolving strategies. Circulation. 2010;121:1235-1243.
6. Routledge HC, Morice MC, Lefevre T, Garot P, De Marco F, Vaquerizo B, Louvard Y. 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch t-stenting using drug-eluting stents. JACC Cardiovasc Interv. 2008;1:358-365.
7. Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, Sheiban I, Paloscia L, Grube E, Schofer J, Bolognese L, Orlandi M, Niccoli G, Latib A, Airoldi F. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: The CACTUS (coronary bifurcations: Application of the crushing technique using sirolimus-eluting stents) study. Circulation. 2009;119:71-78.
8. Latib A, Cosgrave J, Godino C, Qasim A, Corbett SJ, Tavano D, Morici N, Cristell N, Chieffo A, Carlino M, Montorfano M, Airoldi F, Colombo A. Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations. Am Heart J. 2008;156:745-750.
9. Moussa I. Coronary artery bifurcation interventions: Bridging the gap between research and practice. In: Moussa I, Colombo A, eds. Tips and tricks in interventional therapy of coronary bifurcation lesions. London: Informa Healthcare; 2010:16-23.
10. Costa RA, Costa MA, Moussa ID. Bifurcation lesion morphology and intravascular ultrasound assessment. Int J Cardiovasc Imaging. 2011;27:189-196.
11. Costa RA, Kyono H, Costa M, Russell M, Moussa ID. Coronary artery bifurcation lesions: Anatomy. In: Moussa ID, Colombo A, eds. Tips and tricks in interventional therapy of coronary bifurcation lesions. London: Informa Healthcare; 2010:24-35.
12. Fajadet J. The Nile concept. EuroIntervention. 2010;6 Suppl J:J135-138.
13. Del Blanco BG, Marti G, Bellera N, Otaegui I, Serra V, Ferreira I, Domingo E, Angel J, Candell J, Garcia-Dorado D. Clinical and procedural evaluation of the Nile Croco(r) dedicated stent for bifurcations: A single centre experience with the first 151 consecutive non-selected patients. EuroIntervention. 2011;7: 216-224.
14. Medina A, Suarez de Lezo J, Pan M. [a new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.
15. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines onmyocardial revascularization. Eur Heart J.2010;31:2501-2555.
16. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J.2005;26:804-847.
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points incoronary stent trials: A case for standardized definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
18. Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, Cristea E, Gavit L, Costa R, Rares A, Van Es GA, Lefevre T, Reiber H, Louvard Y, Morice MC. Quantitative angiographic methods for bifurcation lesions: A consensus statement from the European Bifurcation Group. Catheter Cardiovasc Interv. 2009;73:258-266.
19. Tuinenburg JC, Koning G, Rares A, Janssen JP, Lansky AJ, Reiber JH. Dedicated bifurcation analysis: Basic principles. Int J Cardiovasc Imaging. 2011;27:167-174.
20. Lefevre T, Darremont O, Albiero R. Provisional side branch stenting for the treatment of bifurcation lesions. EuroIntervention. 2010;6 Suppl J:J65-71.
21. Burzotta F, De Vita M, Sgueglia G, Todaro D, Trani C. How to solve difficult side branch access? EuroIntervention. 2010;6 Suppl J:J72-80.
22. Abizaid A, de Ribamar Costa J, Jr., Alfaro VJ, Feres F, Staico R, Mattos LA, Maldonado G, Sousa JE. Bifurcated stents: Giving toCaesar what is Caesar's. EuroIntervention. 2007;2: 518-525.
23. Ormiston J, Webster M, El-Jack S, McNab D, Plaumann SS. The AST petal dedicated bifurcation stent: First-in-human experience. Catheter Cardiovasc Interv. 2007;70:335-340. (Pubitemid 350194978)
24. Ormiston JA, Lefevre T, Grube E, Allocco DJ, Dawkins KD. First human use of the Taxus Petal paclitaxel-eluting bifurcation stent. EuroIntervention. 2010;6:46-53.